Skip to main content
. 2021 Jun 2;41(6):BSR20204250. doi: 10.1042/BSR20204250

Figure 7. Effects of TMAO on the efferocytosis of RAW264.7 cells.

Figure 7

(A) The efferocytosis of RAW264.7 cells with different treatments (0, 1, 3, 10, 30, 100 μM of TMAO; 24 h) were assessed. (B) The expression levels of MerTK and SR-BI were measured by Western blotting (n=3, *P<0.05, compared with the control group).